Vaxfab FY26 results face auditor disclaimer over records
Vaxfab Enterprises reported a standalone profit of ₹363.80 lakh for FY26, while consolidated results showed a loss of ₹463.08 lakh. Statutory auditors Chandabhoy & Jassoobhoy issued a disclaimer of opinion on both standalone and consolidated financial results due to inadequate record-keeping by previous management and unsecured loans without formal agreements.

*this image is generated using AI for illustrative purposes only.
Vaxfab Enterprises Limited reported a standalone profit of ₹363.80 lakh for the financial year ended March 31, 2026, while its consolidated results reflected a loss of ₹463.08 lakh for the same period. However, the statutory auditors, Chandabhoy & Jassoobhoy, issued a disclaimer of opinion on both the standalone and consolidated financial results due to significant inadequacies in record-keeping and documentation.
The Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026, at a meeting held on May 30, 2026. The audit report highlighted that the company was unable to provide sufficient evidence regarding the completeness and accuracy of balances because certain records pertaining to prior periods were not adequately maintained by the previous management. This included deficiencies in books of account, supporting records, and documentation for sales, purchases, inventory, trade receivables, and trade payables.
Further, the auditors noted that the company had granted and received unsecured loans without formal loan agreements and, in certain cases, without obtaining balance confirmations from the respective parties. The company also failed to maintain requisite records to identify and classify creditors under the Micro, Small and Medium Enterprises Development Act, 2006 (MSMED Act), preventing verification of compliance with disclosure requirements.
Standalone Financial Performance
For the financial year ended March 31, 2026, Vaxfab Enterprises reported total revenue of ₹9959.59 lakh, a significant increase from ₹5937.66 lakh in the previous year. Total expenses for the year stood at ₹9442.12 lakh compared to ₹5867.30 lakh in FY25. The profit before tax for the year was ₹517.47 lakh, up from ₹70.36 lakh in the prior year.
| Particulars | Year Ended 31.03.2026 (₹ in Lacs) | Year Ended 31.03.2025 (₹ in Lacs) |
|---|---|---|
| Total Revenue | 9959.59 | 5937.66 |
| Total Expenses | 9442.12 | 5867.30 |
| Profit Before Tax | 517.47 | 70.36 |
| Net Profit | 363.80 | 58.42 |
| Earnings Per Share (Basic) | 4.33 | 0.70 |
Consolidated Results and Auditor Qualifications
On a consolidated basis, the company reported a total revenue of ₹13675.13 lakh for FY26 against ₹7068.72 lakh in the previous year. However, the consolidated results swung to a loss of ₹463.08 lakh from a profit of ₹48.93 lakh in FY25. The auditors reiterated their disclaimer of opinion for the consolidated results, citing similar issues regarding unsecured loans within the group and the absence of records handed over by the previous management of certain subsidiaries.
The subsidiaries included in the consolidation were Eklingji Tradelink Private Limited and Satvat Agro LLP. The management stated that the qualifications related to the non-accessibility of documents for the time being and asserted that these issues do not have any impact on the financial results.
Historical Stock Returns for Vaxfab Enterprises
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | -2.50% | -3.66% | +30.29% | +229.13% | +582.59% |
What specific remedial measures will the new management implement to rectify the record-keeping deficiencies and satisfy statutory auditors in the next fiscal year?
How will the disclaimer of opinion on the financial results impact Vaxfab Enterprises' ability to secure future funding or maintain credit lines with lenders?
What steps are being taken to regularize the unsecured loans granted and received without formal agreements to mitigate potential financial risks?































